CTI BioPharma, a Seattle-based publicly traded biotech company developing therapies for blood-related cancers, is set to be acquired in a deal with Swedish biotech giant Sobi. The acquisition, announced Wednesday,… Read More
CTI BioPharma announced Thursday that it will let go of half its employees in order to create more runway to develop its experimental drug Pacritinib, which treats the blood cancer… Read More
Seattle-based Appuri, a startup using big data in an attempt to predict customer dissatisfaction, has appointed a new CEO: former Talentwise CEO Todd Owens. Owens replaces Appuri co-founder Damon Danieli, who… Read More